• Je něco špatně v tomto záznamu ?

Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care

S. Toniolo, M. Scarioni, F. Di Lorenzo, J. Hort, J. Georges, S. Tomic, F. Nobili, KS. Frederiksen, Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel

. 2021 ; 82 (3) : 883-898. [pub] -

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026255

Cognitive impairment following SARS-CoV-2 infection is being increasingly recognized as an acute and possibly also long-term sequela of the disease. Direct viral entry as well as systemic mechanisms such as cytokine storm are thought to contribute to neuroinflammation in these patients. Biomarkers of COVID-19-induced cognitive impairment are currently lacking, but there is some limited evidence that SARS-CoV-2 could preferentially target the frontal lobes, as suggested by behavioral and dysexecutive symptoms, fronto-temporal hypoperfusion on MRI, EEG slowing in frontal regions, and frontal hypometabolism on 18F-FDG-PET. Possible confounders include cognitive impairment due to hypoxia and mechanical ventilation and post-traumatic stress disorder. Conversely, patients already suffering from dementia, as well as their caregivers, have been greatly impacted by the disruption of their care caused by COVID-19. Patients with dementia have experienced worsening of cognitive, behavioral, and psychological symptoms, and the rate of COVID-19-related deaths is disproportionately high among cognitively impaired people. Multiple factors, such as difficulties in remembering and executing safeguarding procedures, age, comorbidities, residing in care homes, and poorer access to hospital standard of care play a role in the increased morbidity and mortality. Non-pharmacological interventions and new technologies have shown a potential for the management of patients with dementia, and for the support of their caregivers.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026255
003      
CZ-PrNML
005      
20211026133050.0
007      
ta
008      
211013s2021 ne f 000 0|eng||
009      
AR
024    7_
$a 10.3233/JAD-210335 $2 doi
035    __
$a (PubMed)34092646
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Toniolo, Sofia $u Cognitive Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
245    10
$a Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care / $c S. Toniolo, M. Scarioni, F. Di Lorenzo, J. Hort, J. Georges, S. Tomic, F. Nobili, KS. Frederiksen, Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel
520    9_
$a Cognitive impairment following SARS-CoV-2 infection is being increasingly recognized as an acute and possibly also long-term sequela of the disease. Direct viral entry as well as systemic mechanisms such as cytokine storm are thought to contribute to neuroinflammation in these patients. Biomarkers of COVID-19-induced cognitive impairment are currently lacking, but there is some limited evidence that SARS-CoV-2 could preferentially target the frontal lobes, as suggested by behavioral and dysexecutive symptoms, fronto-temporal hypoperfusion on MRI, EEG slowing in frontal regions, and frontal hypometabolism on 18F-FDG-PET. Possible confounders include cognitive impairment due to hypoxia and mechanical ventilation and post-traumatic stress disorder. Conversely, patients already suffering from dementia, as well as their caregivers, have been greatly impacted by the disruption of their care caused by COVID-19. Patients with dementia have experienced worsening of cognitive, behavioral, and psychological symptoms, and the rate of COVID-19-related deaths is disproportionately high among cognitively impaired people. Multiple factors, such as difficulties in remembering and executing safeguarding procedures, age, comorbidities, residing in care homes, and poorer access to hospital standard of care play a role in the increased morbidity and mortality. Non-pharmacological interventions and new technologies have shown a potential for the management of patients with dementia, and for the support of their caregivers.
650    12
$a Alzheimerova nemoc $x patofyziologie $x psychologie $7 D000544
650    _2
$a biologické markery $x analýza $7 D015415
650    12
$a mozek $x diagnostické zobrazování $x metabolismus $x patofyziologie $x virologie $7 D001921
650    _2
$a COVID-19 $x komplikace $x imunologie $x psychologie $x terapie $7 D000086382
650    12
$a kognitivní dysfunkce $x imunologie $x patofyziologie $x virologie $7 D060825
650    _2
$a komorbidita $7 D015897
650    _2
$a lidé $7 D006801
650    _2
$a neurozobrazování $x metody $7 D059906
650    _2
$a neuroimunomodulace $x imunologie $7 D015213
650    _2
$a péče o pacienta $7 D005791
650    _2
$a SARS-CoV-2 $7 D000086402
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Scarioni, Marta $u Department of Neurology, Amsterdam University Medical Centers, Location VUmc, Alzheimer Center, Amsterdam, The Netherlands $u Department of Pathology, Amsterdam University Medical Centers, Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands
700    1_
$a Di Lorenzo, Francesco $u Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, Brighton, UK $u Non-invasive Brain Stimulation Unit, IRCCS Fondazione Santa Lucia, Rome, Italy
700    1_
$a Hort, Jakub $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Georges, Jean $u Alzheimer Europe, Luxembourg
700    1_
$a Tomic, Svetlana $u Department of Neurology, Osijek University Hospital Center, Osijek, Croatia $u Faculty of Medicine, University Josip Juraj Strossmayer of Osijek, Osijek, Croatia
700    1_
$a Nobili, Flavio $u Neurology Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy $u Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy
700    1_
$a Frederiksen, Kristian Steen $u Danish Dementia Research Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
710    2_
$a Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel
773    0_
$w MED00006350 $t Journal of Alzheimer's disease : JAD $x 1875-8908 $g Roč. 82, č. 3 (2021), s. 883-898
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34092646 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133056 $b ABA008
999    __
$a ok $b bmc $g 1715081 $s 1146762
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 82 $c 3 $d 883-898 $e - $i 1875-8908 $m Journal of Alzheimer's disease $n J Alzheimers Dis $x MED00006350
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace